Modulation of valosin-containing protein by Kyoto University Substances (KUS) as a novel therapeutic strategy for ischemic neuronal diseases

Masayuki Hata; Hanako Ohashi Ikeda

doi:10.4103/1673-5374.213540

🤖This page has been translated by AI and may contain inaccuracies. Please refer to the original content for clarification.

Home>Articles>Modulation of valosin-containing protein by Kyoto University Substances (KUS) as a novel therapeutic strategy for ischemic neuronal diseases

DOI: 10.4103/1673-5374.213540

Modulation of valosin-containing protein by Kyoto University Substances (KUS) as a novel therapeutic strategy for ischemic neuronal diseases

Masayuki Hata

Hanako Ohashi Ikeda

Keywords：adenosine triphosphataseC/EBP homologous proteincentral retinal artery occlusionendoplasmic reticulum stressneuroprotective therapyretinal ganglion cell

Publication Date：2017-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 1252-1255 )

Neural Regeneration Research

ISTICSCI

ISSN：1673-5374

Year, Vol.(Issue)：2017,12(8)